Matches 51 - 88 out of 88 < 1 2
Match Document Document Title
5612036 Synthetic Pseudomonas aeruginosa pilin peptide vaccine  
Treatment and diagnosis of P. aeruginosa infection or colonization is achieved in accordance with this invention by the discovery of a polypeptide which is smaller than the naturally occurring P....
5538727 Anti-cholesterolemic vaccine  
Anti-cholesterolemic eggs are disclosed, said eggs being obtained from animals hyperimmunized against at least one anti-cholesterolemic antigen. A vaccine producing said anti-cholesterolemic egg is...
5512658 Pseudomonas exotoxins (PE) and conjugates thereof having lower animal toxicity with high cytocidal activity through substitution of positively charged amino acids  
Improved Pseudomonas exotoxins of low animal toxicity and high cytocidal activity are described. Substitution of positively charged amino acid residues with an amino acid residue without a positive...
5494672 Pseudomonas peptide composition and method  
A peptide having a sequence corresponding to a C-terminal portion of the Pseudomonas aeruginosa pilin protein is disclosed. The peptide is cross-reactive with surface peptides present in certain...
5458878 P. exotoxin fusio proteins have COOHG220101al alterations which increase cytotoxicity  
A target-specific, cytotoxic, recombinant Pseudomonas exotoxin is described. Such toxins are made by inserting specific recognition molecules at specific cloning sites in at least domain III near...
5324511 Vaccines and immunoglobulin G-containing preparations active against pseudomonas aeruginosa  
Vaccines that are active against Pseudomonas aeruginosa infections contain a single flagellar (H) antigen of serotype a or a combination of a single flagellar (H) antigen of serotype a with a...
5237053 Preparation active against Pseudomonas aeruginosa infections and methods of producing them  
Preparations active against Pseudomonas aeruginosa infections, namely vaccines for active immunization as well as preparations containing antibodies and destined for passive protection; as well as...
5223604 Pseudomonas exoenzyme S peptide composition and method  
A peptide having a sequence corresponding to an antigenic site in the protein exoenzyme S which is antigenically similar to a C-terminal portion of the Pseusdomonas aeruginosa pilin protein is...
5114712 Common antigen (PSC-A) to Pseudomonas aeruginosa which acts as an agent for protecting Pseudomonas aeruginosa infection  
PSC-A is a new serological common antigen to Pseudomonas aeruginosa having very low toxicity, and highly effective for protecting infection by any of the serotypes of Pseudomonas aeruginosa. PSC-A...
5089262 E87Ag antigens of Pseudomonas aeruginosa and monoclonal antibodies against them and hybridomas thereof  
P. aeruginosa E87Ag antigen comprising polysaccharide fraction with molecular weight of about 27,000 which is contained in lipopolysaccharide of P. aeruginosa; anti-P. aeruginosa human or mouse...
4946677 Preparations active against pseudomonas aeruginosa infections and methods of producing them  
Preparations active against Pseudomonas aeruginosa Infections, namely vaccines for active immunization as well as preparations containing antibodies and destined for passive protection; as well as...
4873090 Non-adjuvenated vaccine  
An enteral non-adjuvenated monobacterial vaccine comprising killed bacteria gives a better protection against acute episodes of infection in patients with long term chronic lung disease than a...
4831121 Polydisperse native pseudomonas flagellar (H) antigens (FAg) and methods of producing them  
Polydisperse native Pseudomonas flagellar (H) antigens (FAg) and methods of producing them are described, wherein each monomeric component contains certain amino acids, has a certain N-terminal...
4789544 Co-vaccination using non-O-carbohydrate side-chain gram-negative bacteria preparation  
A composition for co-injection of an animal against a gram-negative pathogen which comprises an effective dose of a gram-negative type lipopolysaccharide devoid of O-carbohydrate side-chains and a...
4771127 Nontoxic pseudomonas aeruginosa polysaccharide-tetanus toxoid and polysaccharide-toxin a conjugate vaccines  
Polysaccharide-protein conjugates were synthesized utilizing polysaccharide derived from hydrolyized Pseudomonas aeruginosa lipopolysacharide covalently coupled to either tetanus toxoid or P....
4764370 Vaccine utilizing an avirulent strain of Salmonella typhimurium  
A vaccine against a microbial pathogen comprised of a live, immunogenic but prototrophic and avirulent mutant strain of the selected microbial pathogen in an amount effective to confer immunity. A...
4762713 Boosting of immunogenic conjugate vaccinations by unconjugated bacterial capsular polymers  
This invention relates to immunogenic conjugates of capsular polymers or polymer fragments from bacterial pathogens and bacterial toxins, toxoids or subunits. The invention also relates to methods...
4711779 Glycoproteinic conjugates having trivalent immunogenic activity  
Glycoproteinic conjugates having trivalent immunogenic activity obtained by binding, by a covalent bond, to a protein selected among CRM 197, tetanus toxoid, and pertussis toxin, at least an...
4707543 Process for the preparation of detoxified polysaccharide-outer membrane protein complexes, and their use as antibacterial vaccines  
Process for preparing a detoxified polysaccharide-outer membrane protein complex from bacterial envelopes; the so-obtained products which are useful as vaccines against infection by the same...
4693891 Vaccine for Pseudomonas aeruginosa  
There is disclosed an immunizing composition comprising a non-toxic polysaccharide isolated from gram-negative bacteria, especially from Pseudomonas aeruginosa, covalently coupled to a non-toxic...
4663160 Vaccines for gram-negative bacteria  
An immunizing composition is disclosed and comprises a detoxified polysaccharide from a gram-negative bacterium covalently coupled to a detoxified protein from said gram-negative bacterium by means...
4578458 Mucoid exopolysaccharide vaccine against Pseudomonas aeruginosa  
A method of inducing an immune response against multiple strains of Pseudomonas aeruginosa which comprises administering to a human or animal an amount of mucoid exopolysaccharide from Pseudomonas...
4575459 Toxoids of elastase of Pseudomonas aeruginosa origin  
Provided herein are two kinds of toxoid of elastase of Pseudomonas aeruginosa origin, one of which is obtained by treating a purified elastase produced from Pseudomonas aeruginosa with a synthetic...
4488991 Bacterial toxoids and gram-negative immune globulin therefrom  
ADP-Ribosylating toxins are rendered enzymatically inactive by reactions with photolabile affinity reagents. The toxoids retain the antigenic and immunogenic properties of the original toxins....
4470924 Nontoxic, immunologically crossreactive toxin A protein from Pseudomonas aeruginosa  
A nontoxic, immunologically crossreactive toxin A protein produced by a PAO-PR1 mutant strain of Pseudomonas aeruginosa. The protein, in activated form, has substantially no adenosine...
4402939 Vaccinating glycopeptidic antigenic fraction with a very high level of immunogenicity, isolated from cultures of pathogenic germs, processes for isolating said fraction and vaccines containing said fraction  
A glycopeptic vaccinating antigenic fraction with a very high level of immunogenicity, which is isolated from a culture of pathogenic germs comprises an osidic part present in a proportion of about...
4285936 Method for producing a vaccine against bacterial infections caused by pseudomonas aeruginosa  
A method for isolating a non toxic, high molecular weight polysaccharide igen from the crude slime of a Pseudomonas aeruginosa culture, and a method for inducing immunity in a host to said live...
4167560 Polyvalent shipping fever vaccine  
Veterinary compositions of matter useful as vaccines in the biologic treatment of a multifaceted livestock disease syndrome which is commonly referred to as "shipping fever", the present...
4160023 Toxoids derived from protease and elastase of Pseudomonas aeruginosa and production thereof  
Toxoids derived from protease and elastase of Pseudomonas aeruginosa which are effective to prevent infections caused by Pseudomonas aeruginosa and production thereof.
4157389 Mixed vaccine against infections by pseudomonas aeruginosa  
A three component-mixed vaccine against infections caused by Pseudomonas aeruginosa which comprises as the antigens an infection-protective common antigen OEP (Original Endotoxin Protein) obtained...
4096245 Prophylactic preparation for treating mink infection caused by Pseudomonas aeruginosa  
Mink infection caused by Pseudomonas aeruginosa can be prevented by administering to mink a prophylactic preparation in the form of vaccine whose effective component is a compound mainly consisting...
4083959 Therapeutical method for treating infection of mink hemorrhagic pneumonitis  
A therapeutic preparation of a bacterial component (designated as OEP and formally as CWP) derived from Pseudomonas aeruginosa possesses vaccine activity (the effective component being a...
4079126 Method of preparing a component consisting of sugar, lipid and protein derived from Pseudomonas aeruginosa which possess anti-tumor and interferon inducing properties  
This invention relates to a method of preparing original endotoxin protein of Pseudomonas aeruginosa. The invention relates more particularly to a method of preparing original endotoxin protein of...
3987164 Method for prevention of pseudomonas aeruginosa infections  
The invention involves vaccine preparations comprising cell wall protein component of Pseudomonas aeruginosa as active ingredient and a pharmaceutically acceptable carrier. The preparations are...
3928565 Pharmaceutical preparation of pseudomonas aeruginosa bacterial component possessing anti-tumor and anti-infection properties  
Anti-tumor and vaccine preparations comprising cell wall protein component of Pseudomonas aeruginosa as active ingredient and a pharmaceutically acceptable carrier. The preparations are suitable...
3674863 POLYVALENT IMMUNIZING AGENTS AND METHODS FOR THEIR PRODUCTION  
Polyvalent antigens, including polyvalent vaccines, containing immunizing antigens from two or more selected strains of Pseudomonas aeruginosa. Optionally, the polyvalent antigens are administered...
3450815 METHOD OF STIMULATING A HOST DEFENSE MECHANISM WITH AN ACTINOVACCINE  
3658986 Title is not available  
Matches 51 - 88 out of 88 < 1 2